Marianne Jansson
41 – 60 of 70
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Boosting of HIV-1 Neutralizing Antibody Responses by a Distally Related Retroviral Envelope Protein.
(
- Contribution to journal › Article
-
Mark
HIV-2 Infection : The Role of Immune Activation in Pathogenesis
2014) p.1-8(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Transmission HIV-2: Origin, Epidemiology, and Phenotype
2014) p.1-9(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model
(
- Contribution to journal › Article
-
Mark
R5 HIV-1 with efficient DC-SIGN use is not selected for early after birth in vertically infected children.
(
- Contribution to journal › Article
-
Mark
Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent
(
- Contribution to journal › Article
-
Mark
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
(
- Contribution to journal › Article
-
Mark
Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.
(
- Contribution to journal › Article
-
Mark
Frequent intratype neutralization by plasma immunoglobulin A identified in HIV-2 infection.
(
- Contribution to journal › Article
- 2012
-
Mark
Mycobacteria-infected bystander macrophages trigger maturation of dendritic cells and enhance their ability to mediate HIV transinfection
(
- Contribution to journal › Article
-
Mark
Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1
(
- Contribution to journal › Article
-
Mark
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
(
- Contribution to journal › Article
-
Mark
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
(
- Contribution to journal › Article
-
Mark
Tuberculosis and HIV Co-Infection
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Reply to Redd et al
(
- Contribution to journal › Letter
-
Mark
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(
- Contribution to journal › Article
- 2010
-
Mark
Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
(
- Contribution to journal › Published meeting abstract
-
Mark
Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
(
- Contribution to journal › Published meeting abstract